Chronic urticaria therapeutics(Enanta Pharmaceuticals)

N/A

Report date: 2024/05/27 10:16:41
NME

Base Information

Drug NameChronic urticaria therapeutics(Enanta Pharmaceuticals)
Drug Alias NameCSU(Enanta Pharmaceuticals)
ClassificationSmall molecules
Mechanisms of ActionStem cell growth factor receptor inhibitors
TargetsStem cell growth factor receptor
Therapy Area/IndicationsChronic Urticaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnanta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnanta Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsChronic Urticaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A